Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models-Reference-Cited by-同舟云学术

Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models

Published:2017-03-13 Issue:18 Volume:8 Page:29865-29886
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Gravina Giovanni Luca¹²,Mancini Andrea²,Mattei Claudia³,Vitale Flora³,Marampon Francesco²,Colapietro Alessandro²,Rossi Giulia²,Ventura Luca³,Vetuschi Antonella⁴,Di Cesare Ernesto¹,Fox Judith A.⁵,Festuccia Claudio²

Affiliation:

1. Department of Biotechnological and Applied Clinical Sciences, Division of Radiotherapy, University of L’Aquila, L’Aquila, Italy

2. Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L’Aquila, L’Aquila, Italy

3. Department of Biotechnological and Applied Clinical Sciences, Laboratory of Neurosciences, University of L’Aquila, L’Aquila, Italy

4. Department of Biotechnological and Applied Clinical Sciences, Chair of Human Anatomy, University of L’Aquila, L’Aquila, Italy

5. Sunesis Pharmaceuticals Inc., South San Francisco, CA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma;Frontiers in Pharmacology;2022-03-23

3. Crocetin Mitigates Irradiation Injury in an In Vitro Model of the Pubertal Testis: Focus on Biological Effects and Molecular Mechanisms;Molecules;2021-03-17

4. Influence of Lipoxygenase Inhibition on Glioblastoma Cell Biology;International Journal of Molecular Sciences;2020-11-09

5. Considering the Experimental Use of Temozolomide in Glioblastoma Research;Biomedicines;2020-06-04